Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients
Evaluation of Oxygenation by 100% Oxygen Via High Flow Nasal Cannula During Apnea in Adult Elective Surgical ENT Patients
1 other identifier
interventional
31
0 countries
N/A
Brief Summary
Oxygenation with high-flow nasal cannula with 100% oxygen has only been evaluated in a limited number of studies. Although data are convincing it is of importance to evaluate this new concept in our department before implementing it into clinical practice. The general purpose of this project is to evaluate a new ventilation strategy during ENT-surgery based on oxygenation with high-flow nasal cannula with 100% oxygen with focus on gas exchange.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 15, 2015
CompletedFirst Posted
Study publicly available on registry
March 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedDecember 19, 2017
December 1, 2017
7 months
December 15, 2015
December 17, 2017
Conditions
Outcome Measures
Primary Outcomes (3)
Change in arterial carbon dioxide (pCO2)
From start of anaesthesia to end of apnoea oxygenation or max 30 minutes
Change in arterial pH
From start of anaesthesia to end of apnoea oxygenation or max 30 minutes
Change in arterial oxygen tension (pO2)
From start of anaesthesia to end of apnoea oxygenation or max 30 minutes
Secondary Outcomes (4)
Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pCO2 in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?
In the end of the apnoea period, i.e. at approximately 20 minutes
Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pH in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?
In the end of the apnoea period, i.e. at approximately 20 minutes
Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pO2 in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?
In the end of the apnoea period, i.e. at approximately 20 minutes
Does the high oxygen content cause atelectasis measures as change in relation between pCO2 and end tidal carbon dioxide
Until discharge from the postoperative unit, often max 2 hours
Study Arms (2)
Normoventilation
NO INTERVENTIONThe patients will be normoventilated before anesthesia
Hyperventilation
EXPERIMENTALPrior to anesthesia, the patients will hyperventilate during 2 mins or until symptoms from the central nervous system (e.g. dizziness).
Interventions
Eligibility Criteria
You may qualify if:
- Adult, \>18 years old
- ENT-surgery where apnea is of benefit for the surgeon (eg. intraoral or laryngeal surgery) and the anesthesia time is \<40 mins.
- Capable of understanding the study information and sign the written consent.
You may not qualify if:
- ASA\>2
- NYHA \>2
- BMI \>30
- Pregnancy
- Manifest cardiac failure or coronary disease
- Neuromuscular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Gustafsson IM, Lodenius A, Tunelli J, Ullman J, Jonsson Fagerlund M. Apnoeic oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) - a physiological study. Br J Anaesth. 2017 Apr 1;118(4):610-617. doi: 10.1093/bja/aex036.
PMID: 28403407DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malin Jonsson Fagerlund, MD, PhD
Karolinska University Hospital and Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor/Senior Consultant
Study Record Dates
First Submitted
December 15, 2015
First Posted
March 11, 2016
Study Start
December 1, 2015
Primary Completion
June 30, 2016
Study Completion
September 1, 2016
Last Updated
December 19, 2017
Record last verified: 2017-12